Overexpressed CXCR4 and CCR7 on the surface of NK92 cell have improved migration and anti-tumor activity in human colon tumor model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overexpressed CXCR4 and CCR7 on the surface of NK92 cell have improved migration and anti-tumor activity in human colon tumor model

Published:2020-04 Issue:4 Volume:31 Page:333-344
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Yang Lili,Huang Changxin,Wang Congjie,Zhang Siyu,Li Zhaoyang,Zhu Ying,Li Da,Gao Lanlan,Ge Zuanmin,Su Meng,Feng Xi,Li Yongqiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference42 articles.

1. PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-erk1/2 pathway.;Cheng;Mol Cancer,2018

2. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.;Louis;Blood,2011

3. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.;Pule;Nat Med,2008

4. Regression of glioblastoma after chimeric antigen receptor T-cell therapy.;Brown;N Engl J Med,2016

5. The generation of CAR-transfected natural killer T cells for the immunotherapy of melanoma.;Simon;Int J Mol Sci,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

2. Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease;European Journal of Medicinal Chemistry Reports;2024-04

3. Development of NK cell-based cancer immunotherapies through receptor engineering;Cellular & Molecular Immunology;2024-03-05

4. Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells;Molecular Therapy: Oncology;2024-03

5. Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment;Frontiers in Immunology;2023-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3